While CD52 expression was highly variable from case to case, convincing cytoplasmic and/or membranous expression was observed in the majority of both DHL (75%) and DEL (75%), at levels consistent with prior studies of aggressive mature B-cell lymphomas[14]. This evidence concerns the gene CD52 and B-cell non-Hodgkin lymphoma.